IRIS
OREFICE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.142
EU - Europa 662
AS - Asia 228
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.099
IT - Italia 296
CN - Cina 190
NL - Olanda 108
FI - Finlandia 78
IE - Irlanda 66
DE - Germania 51
CA - Canada 43
UA - Ucraina 22
CI - Costa d'Avorio 21
GB - Regno Unito 17
SE - Svezia 14
IN - India 12
VN - Vietnam 12
FR - Francia 5
IR - Iran 4
KR - Corea 4
MK - Macedonia 3
SG - Singapore 3
TR - Turchia 2
AE - Emirati Arabi Uniti 1
EU - Europa 1
HR - Croazia 1
NO - Norvegia 1
Totale 2.054
Salva come PNG Salva come JPEG
Città #
Chandler 209
Amsterdam 104
Naples 85
Ashburn 80
Princeton 80
Millbury 75
Beijing 58
Nanjing 57
Ottawa 38
Boston 36
Wilmington 32
Napoli 29
Jacksonville 28
Des Moines 27
Norwalk 23
Nanchang 17
Seattle 16
Hebei 14
Dong Ket 12
Jiaxing 11
Shenyang 10
Milan 9
Tianjin 9
Augusta 8
Rome 8
Houston 7
Pune 6
Redwood City 6
Boardman 5
Sant'arpino 5
Woodbridge 5
Dublin 4
Falls Church 4
Guangzhou 4
Indiana 4
Los Angeles 4
San Mateo 4
Avezzano 3
Bari 3
Catania 3
Florence 3
Lanzhou 3
Leawood 3
Marigliano 3
Palermo 3
Sessa Aurunca 3
Taranto 3
Toronto 3
Washington 3
Ardabil 2
Caserta 2
Castellammare Di Stabia 2
Changsha 2
Cologne 2
Dalmine 2
Dearborn 2
Helsinki 2
Kronberg 2
Positano 2
Redmond 2
Salerno 2
Toulouse 2
Trieste 2
Walnut 2
Altamura 1
Ankara 1
Ann Arbor 1
Barrie 1
Bologna 1
Brescia 1
Cardito 1
Centro 1
Changchun 1
Como 1
Corsano 1
Crotone 1
Cumming 1
Dundas 1
Düsseldorf 1
Edison 1
Fremont 1
Gragnano 1
Inzago 1
Islington 1
Krimpen Aan Den Ijssel 1
Kunming 1
L'aquila 1
Lawrence 1
Librizzi 1
London 1
Newark 1
Newbury Park 1
Nocera Superiore 1
Oxford 1
Pagani 1
Pontecagnano 1
Pontefract 1
Potenza 1
San Diego 1
San Giuseppe Vesuviano 1
Totale 1.235
Salva come PNG Salva come JPEG
Nome #
Nuove tecniche di imaging nello studio delle alterazioni perfusionali cerebrali e dei processi di degenerazione neuronale in soggetti affetti da sclerosi multipla e da altre patologie neurologiche degenerative. Associazioni tra marcatori radiologici e polimorfismi genetici di predisposizione e decorso delle malattie neurodegenerative 84
The effects of mechanical focal vibration on walking impairment in multiple sclerosis patients: A randomized, double-blinded vs placebo study 64
The Heterogeneity of Early Parkinson?s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 52
Brain atrophy and lesion load in a large population of patients with multiple sclerosis 49
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 49
Anatomical and functional retinal changes in multiple sclerosis 48
Aerodynamic findings and Voice Handicap Index in Parkinson’s disease 47
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. 44
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis 43
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. NeuroImage18: 360-366, 2003.. 41
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. 41
Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junction 40
Epileptic seizures in multiple sclerosis: clinical and EEG correlations. 38
Communication in Multiple Sclerosis: Pragmatic Deficit and its Relation with Cognition and Social Cognition 38
Multiple sclerosis and headache co-morbidity. A case-control study 36
Age-related risk factors for ischemic stroke in Italian men. 36
Analisi conoscitiva del grado di aderenza di strutture di riabilitazione alle principali linee guida nazionali nel trattamento di pazienti afasici e disfagici. 36
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells 36
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis 36
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 35
Inhibition of oligodendrocyte differentiation by immunoglobulin purified from serum of multiple sclerosis patients during relapse 34
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. 33
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(®) 33
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 32
Comparative effects of mesoglycan and ticlopidine treatment on some coagulative parameters in patients with previous ischemic stroke: Results of a randomized controlled trial 32
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis 31
An open label randomised clinical trial of atorvastatin in combination with IFN beta-1a in active MS patients: 12 months results. 31
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta. 30
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 30
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. 29
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. 29
Vitamin D in a population of Southern Italy relapsing remitting and secondary progressive multiple sclerosis patients. 28
Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study. 27
Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. 27
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region 27
Brain atrophy in Relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study). 27
Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b. 26
Benign intracranial hypertension of obese women. A twenty cases report. 26
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 26
B-thromboglobulin and Platelet Factor-4 Measured By A Radioimmunoassay As Indexes of Platelet Activation In Patients With Migraine 25
Prognostic value of combined target-organ damage in patients with essential hypertension 25
A voxel-based morphometry study of disease severity correlates in relapsing-remitting multiple sclerosis 24
Switching disease-modifying therapies in multiple sclerosis: follow-up of 108 patients. In MULTIPLE SCLEROSIS (Vol. 11, pp. S159-S159). 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND: HODDER ARNOLD, HODDER HEADLINE PLC. 24
Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. 23
Clinical and computerized tomographic study of a case of Schilder's disease. 23
Three primitive reflexes in HIV-1-infected individuals: a possible clinical marker of early central nervous system involvement. 23
Transient global amnesia in a young woman on prolonged treatment with oral contraceptive drugs. 22
Recurrent pulmonary and cerebral thromboembolism in an adult patients following incomplete removal of ventriculoatrial shunt for congenital hydrocephalus. 22
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 22
Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy. 21
Antithrombotic effect of indobufen in an experimental model of arterio-arterial microanastomosis in the rat. 21
Spontaneous resolution of Chiari type 1 malformation. A case report and literature review 21
No effect of cloricromen on some coagulation parameters in patients with ischaemic cerebrovascular disease. 20
Gender differences in non-motor symptoms in early, drug naive Parkinson's disease 20
Post-exercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation: a study in multiple sclerosis 19
Regional GM loss in MS: a comparison between Primary-Progressive and Relapsing-Remitting MS phenotypes. 19
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinject on over a 1-year period: the CoSa study. 18
[The physiopathology of supranuclear structures in oculomotor disorders]. 18
HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis. 17
Successful treatment of paraneoplastic cerebellar degeneration with Rituximab. 17
Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. 17
No effect of acetylsalicylic acid on B-thromboglobulin and platelet factor 4 plasma levels in patients with transient ischaemic attacks. 17
Do gonadotropins play a role in catamenial epilepsy? | [Le gonadotropine ipofisarie hanno un ruolo nella patogenesi delle crisi catameniali?]. 17
Microalbuminuria predicts the recurrence of cardiovascular events in patients with essential hypertension 17
Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and secondary progressive IFN beta treated MS patients 17
Serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis 17
Dati aerodinamici della voce dei soggetti con malattia di Parkinson preliminari al trattamento riabilitativo logopedico 17
[Fahr syndrome with and without hypoparathyroidism. 2 cases]. 16
NAbs effect on cognitive, clinical and quantitative MRI outcome measures in RR-MS IFN beta-1b treated patients 16
No effect of cloricromen on some coagulation parameters in patients with ischaemic cerebrovascular disease. 15
Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population 15
Idiopathic intracranial hypertension in a patient with thyroid papillary carcinoma 14
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis. 13
Platelet-function In Childhood Migraine 13
Epilepsy and multiple sclerosis: Review of literature and our epilepsy center's experience 13
Natalizumab vs interferon beta 1a inrelapsing-remitting multiple sclerosis: a head-to-head retrospective study. 12
Presence of papova-like viral particles in cerebrospinal fluid of AIDS patients with progressive multifocal leukoencephalopathy. An additional test for "in vivo" diagnosis. 11
Subcutaneous interferon ?-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. 11
Usefulness of the Radioimmunoassay of B-thromboglobulin In Transient Ischemic Attacks 10
Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients. 9
Interferon beta-1a and atorvastatin combination therapy: 12-month results from an open-label, randomized, clinical study. 7
Is brain atrophy progression in RR-MS slowed by the association off atorvastatin and interferon beta-1a? Preliminary results from an open-label, randomized, clinical study 7
Totale 2.196
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.722
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 6 2
2019/2020254 110 17 6 1 10 2 3 8 3 26 51 17
2020/2021144 18 4 6 9 8 13 6 1 19 1 43 16
2021/2022416 5 0 0 2 1 18 1 16 69 48 88 168
2022/2023545 83 38 18 25 73 45 0 40 76 104 26 17
2023/2024386 15 71 117 37 32 46 10 44 5 7 2 0
Totale 2.196